GO2 for Lung Cancer, Dana-Farber Cancer Institute, and Addario Lung Cancer Medical Institute Announce Expansion of Landmark Patient Research on Underlying Causes of Inherited Risk of Lung Cancer

2024-04-17T09:08:46-05:00April 17th, 2024|Hot Topics, News, Press Releases, Science and Research|

Clinical Trial Aims to Unlock the Origins of Lung Cancer   WASHINGTON and BOSTON, April 17, 2024 – In a promising step forward, GO2 for Lung Cancer (GO2), Dana-Farber Cancer Institute (Dana-Farber), and the Addario Lung Cancer Medical Institute (ALCMI), [...]

How One Survivor Became an Advocate: Perspectives from a Voices Summit First-Timer

2024-03-20T15:11:37-05:00March 19th, 2024|Advocacy in Action, Hot Topics, Monthly Measure, Newsletter Articles|

Earlier this month, Oakland-based photographer Genevieve joined nearly 200 other lung cancer advocates in Washington, D.C., to share her story with Congressional members and urge support for lung cancer research. We talked to her about her experience as one [...]

GO2 for Lung Cancer Holds Lung Cancer Voices Summit on Capitol Hill to Advocate for Increased Research Funding for the Leading Cause of Cancer Death

2024-03-04T10:21:55-06:00March 4th, 2024|Advocacy in Action, Hot Topics, News, Press Releases|

More than 230,000 Americans will die of lung cancer this year WASHINGTON, March 4, 2024 - On Tuesday, March 5 GO2 for Lung Cancer (GO2) will host more than 200 supporters on Capitol Hill to educate members of Congress on the [...]

Go to Top